Congestive heart failure echocardiography: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:


== Overview==
== Overview==
[[Echocardiography]] is commonly used to support a clinical diagnosis of heart failure. This modality uses [[ultrasound]] to determine the [[stroke volume]] (SV, the amount of blood in the heart that exits the ventricles with each beat), the [[end-diastolic volume]] (EDV, the total amount of blood at the end of diastole), and the SV in proportion to the EDV, a value known as the ''[[ejection fraction]]'' (EF). In pediatrics, the [[shortening fraction]] is the preferred measure of systolic function. Normally, the EF should be between 50% and 70%; in systolic heart failure, it drops below 40%. Echocardiography can also identify valvular heart disease and assess the state of the [[pericardium]] (the connective tissue sac surrounding the heart). Echocardiography may also aid in deciding what treatments will help the patient, such as medication, insertion of an [[implantable cardioverter-defibrillator]] or [[cardiac resynchronization therapy]]. Echocardiography can also help determine if acute myocardial ischemia is the precipitating cause, and may manifest as regional wall motion abnormalities on echo.
[[Echocardiography]] is commonly used to diagnose and monitor the progress of heart failure. This modality uses [[ultrasound]] to determine the [[stroke volume]] (SV, the amount of blood in the heart that exits the ventricles with each beat), the [[end-diastolic volume]] (EDV, the total amount of blood at the end of diastole), and the SV divided by the EDV, a value known as the ''[[ejection fraction]]'' (EF). In pediatrics, the [[shortening fraction]] is the preferred measure of systolic function.


==Abnormalities Detected / Evaluated on Echocardiography in Congestive Heart Failure==
==Abnormalities Detected / Evaluated on Echocardiography in Congestive Heart Failure==
*Evaluation of left ventricular function and [[ejection fraction]]  
Echocardiography can be used in the following ways:
*Wall motion abnormalities  
* To evaluate left ventricular function and [[ejection fraction]] to distinguish [[systolic dysfunction]] with a low ejection fraction (<40%) from [[diastolic dysfunction]] with a preserved ejection fraction.
*Detection of [[mitral regurgitation]]  
* To assess for the presence of regional wall motion abnormalities that would suggest an ischemic basis for the heart failure
*Detection of [[aortic stenosis]]  
* Detection and quantification of [[mitral regurgitation]]
*Measurement of [[pulmonary artery pressure]]
* Detection and quantification oof [[aortic stenosis]]  
*Detection and evaluation of [[aneurysms]]
* Measurement of [[pulmonary artery pressure]]
* Pericardial diseases such as [[cardiac tamponade]] can be rapidly diagnosed by echocardiography.
* Echocardiography may also aid in deciding what treatments will help the patient, such as medication, insertion of an [[implantable cardioverter-defibrillator]] or [[cardiac resynchronization therapy]].


== References==
== References==

Revision as of 11:44, 3 April 2012

Congestive Heart Failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Systolic Dysfunction
Diastolic Dysfunction
HFpEF
HFrEF

Causes

Differentiating Congestive heart failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Clinical Assessment

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Cardiac MRI

Echocardiography

Exercise Stress Test

Myocardial Viability Studies

Cardiac Catheterization

Other Imaging Studies

Other Diagnostic Studies

Treatment

Invasive Hemodynamic Monitoring

Medical Therapy:

Summary
Acute Pharmacotherapy
Chronic Pharmacotherapy in HFpEF
Chronic Pharmacotherapy in HFrEF
Diuretics
ACE Inhibitors
Angiotensin receptor blockers
Aldosterone Antagonists
Beta Blockers
Ca Channel Blockers
Nitrates
Hydralazine
Positive Inotropics
Anticoagulants
Angiotensin Receptor-Neprilysin Inhibitor
Antiarrhythmic Drugs
Nutritional Supplements
Hormonal Therapies
Drugs to Avoid
Drug Interactions
Treatment of underlying causes
Associated conditions

Exercise Training

Surgical Therapy:

Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)
Implantation of Intracardiac Defibrillator
Ultrafiltration
Cardiac Surgery
Left Ventricular Assist Devices (LVADs)
Cardiac Transplantation

ACC/AHA Guideline Recommendations

Initial and Serial Evaluation of the HF Patient
Hospitalized Patient
Patients With a Prior MI
Sudden Cardiac Death Prevention
Surgical/Percutaneous/Transcather Interventional Treatments of HF
Patients at high risk for developing heart failure (Stage A)
Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
Patients with current or prior symptoms of heart failure (Stage C)
Patients with refractory end-stage heart failure (Stage D)
Coordinating Care for Patients With Chronic HF
Quality Metrics/Performance Measures

Implementation of Practice Guidelines

Congestive heart failure end-of-life considerations

Specific Groups:

Special Populations
Patients who have concomitant disorders
Obstructive Sleep Apnea in the Patient with CHF
NSTEMI with Heart Failure and Cardiogenic Shock

Congestive heart failure echocardiography On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Congestive heart failure echocardiography

CDC on Congestive heart failure echocardiography

Congestive heart failure echocardiography in the news

Blogs on Congestive heart failure echocardiography

Directions to Hospitals Treating Congestive heart failure echocardiography

Risk calculators and risk factors for Congestive heart failure echocardiography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Echocardiography is commonly used to diagnose and monitor the progress of heart failure. This modality uses ultrasound to determine the stroke volume (SV, the amount of blood in the heart that exits the ventricles with each beat), the end-diastolic volume (EDV, the total amount of blood at the end of diastole), and the SV divided by the EDV, a value known as the ejection fraction (EF). In pediatrics, the shortening fraction is the preferred measure of systolic function.

Abnormalities Detected / Evaluated on Echocardiography in Congestive Heart Failure

Echocardiography can be used in the following ways:

References

Template:WH Template:WS